Novartis lays out $256M for antibody plant expansion in Singapore, plots 100 hires

Over the years, Singapore has attracted a suite of biopharma majors, and Novartis is no exception.

Now, the Swiss drugmaker is upping its commitment there with plans for an antibody manufacturing expansion designed to address “soaring demand in the Asian market.”